Skip to main content

ARMISTICE CAPITAL, LLC

Position in AUTL — Autolus Therapeutics plc

CIK 1601086 NEW YORK, NY

Position in AUTL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$24,000,000
+$2,196,000 QoQ
Shares Held
15,000,000
-5.1% QoQ
Ownership
5.64%
of shares outstanding
% of Portfolio
0.67%
of 13F equity value
Holder Rank
#4
of 84 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AUTL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ARMISTICE CAPITAL, LLC holds $1,506,954,940 across 50 Biotechnology names. AUTL ranks #21 (1.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AUTL

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $24,000,000 15,000,000
2026-06-30 $24,000,000 15,000,000
2026-03-31 $21,804,000 15,800,000
2025-12-31 $34,825,000 17,500,000
2025-09-30 $25,428,000 15,600,000
2025-06-30 $27,360,000 12,000,000
2025-03-31 $17,050,000 11,000,000
2024-12-31 $21,620,000 9,200,000
2024-09-30 $24,945,360 6,872,000
2024-06-30 $21,750,000 6,250,000
2024-03-31 $29,807,360 4,672,000
2023-12-31 $24,794,000 3,850,000
2023-09-30 $16,077,000 6,900,000
2023-06-30 $17,288,320 7,264,000
2023-03-31 $17,796,480 9,672,000
2022-12-31 $19,425,600 10,224,000